Market capitalization | $198.63m |
Enterprise Value | $46.30m |
P/E (TTM) P/E ratio | 27.17 |
EV/FCF (TTM) EV/FCF | 1.37 |
EV/Sales (TTM) EV/Sales | 0.07 |
P/S ratio (TTM) P/S ratio | 0.29 |
P/B ratio (TTM) P/B ratio | 0.96 |
Dividend yield | 36.12% |
Last dividend (FY22) | $6.56 |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
2 Analysts have issued a Medifast Inc forecast:
2 Analysts have issued a Medifast Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 674 674 |
45%
45%
|
|
Gross Profit | 498 498 |
43%
43%
|
|
EBITDA | 26 26 |
86%
86%
|
EBIT (Operating Income) EBIT | 11 11 |
94%
94%
|
Net Profit | 7.33 7.33 |
94%
94%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its platform includes OPTAVIA, which offers its costumers lifelong transformation, one healthy habit at a time. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD
Head office | United States |
CEO | Daniel Chard |
Employees | 634 |
Founded | 1981 |
Website | www.medifastinc.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.